|
The 3rd Joint Meeting of the Association of British Clinical
Diabetologists
and the Renal Association
Diabetes and Kidney Disease: Advances and Controversies
Tuesday 28th February 2017
National Exhibition Centre, Birmingham
POSTERS FOR ONLINE VIEWING
1
Is Methoxy polyethylene glycol-epoetin
beta better than shorter acting erythropoesis stimulating agents in
treating anaemia of chronic kidney disease in patients on dialysis.
Al-Chalabi S (1).
(1) University of Buckingham .
Poster not available for online viewing
2
Improved patient care and
efficiency savings following the introduction of a virtual
integrated multidisciplinary diabetic renal meeting.
Avari, P (1), Shapriya, K (1), Lewington-Gower E (1),
Cairns, T (1), Pokrajac, A (1).
(1) Diabetes and Endocrinology Department, Watford General
Hospital.
Click here to view poster
3
Insulin glargine 300 U/mL
(Gla-300) provides more stable and more evenly distributed
steady-state pharmacodynamic (PD) and pharmacokinetic (PK) profiles
compared with insulin degludec in type 1 diabetes (T1DM).
Dahmen R; Pettus J; Roussel R; Bergmann K; Maroccia M; Nassr
N; Klein O; Bolli G; Heise T.
AMCR Institute, Escondido, CA, USA; Sanofi, Frankfurt am
Main, Germany; University of California, San Diego, CA, USA;
Assistance Publique Hôpitaux de Paris, Bichat Hospital, Paris,
France; Umanis, Levallois-Perret, France; Profil, Neuss, Germany;
University of Perugia, Perugia, Italy. Study supported by Sanofi.
Poster not available for online viewing
4
Characteristics of patients with
diabetes admitted with AKI (Acute Kidney Injury) in a District
General Hospital.
George S (1), Berresford C (1), Morlidge C (1), Winocour P
(1) Marshall C (1).
(1) East and North Hertfordshire NHS Trust.
Click here to view poster
5
Medicines management in patients with
diabetes admitted with AKI (Acute Kidney Injury) in a District
General Hospital.
Marshall, C (1), Berresford C
(1), Morlidge C (1), Winocour P
(1), George S (1).
(1) East and North Hertfordshire NHS Trust.
Click here to view poster
6
Monitoring and management of
Cardiovascular risk factors in patients with advanced diabetic
nephropathy.
Kashif, M (1), Gulfam, T
(1), Aslam, MW (1), Ferriman,
C; Mada, S (1).
(1) Department of diabetes and endocrinology, University
Hospital of Durham, County Durham and Darlington NHS Foundation
Trust, UK.
Poster not available for online viewing
7
The clinical significance of blood ketone
measurement in hyperglycaemic in-patients with insulin treated
diabetes mellitus and end stage renal failure.
Huang, F (1), Koo M
(1), McMillan M (1), Ghouri N
(1).
(1) Queen Elizabeth University Hospital, Glasgow
Click here to view poster
8
Audit of haemodialysis inpatient with
comorbid diabetes.
Kumela
HH (1), Lomas J (1),
Patel D (1), Francis MRB (1),
Shiu KY(1), Hailu F
(1).
(1) Diabetes Department Royal Free London NHS Trust
Poster not available for online viewing
9
Early Death in Type 1 Diabetes.
McPherson H (1), McKnight
J (1),
Ritchie S (1).
(1) University of Edinburgh. (2) Western General Hospital,
NHS Lothian.
Click here to view poster
10
Outcome of Renal Biopsy in patients with
Diabetes.
Madhyastha, R (1), Mariah, S
(1).
(1) Dorset County Hospital.
Poster not available for online viewing
11
An unusual case of rapidly progressive
chronic kidney failure in patient with insulin treated Type 2
diabetes and chronic microvascular complications.
Marga M (1),
Pinto LP (1),
Coulson RM (1) Carrington C (2), Roberts G (2), .
(1) Department of Diabetes and Endocrinology, Nevill Hall
Hospital; (2) Department of Nephrology Royal Gwent Hospital, ABUHB;
Department of Pathology, UHW.
Click here to view poster
12
Three-times-weekly insulin therapy: the
Hammersmith haemodialysis experience.
Mills, E (1),Yap H
(1), Reed J (1), Dornhurst A
(1).
(1) Imperial Centre for Endocrinology: (Hammersmith
Hospital), Imperial College Healthcare NHS Trust.
Click here to view poster
13
Anti-diabetic therapy in patients with
type 2 diabetes and renal impairment.
Min, T (1,2), Davies GI (3), Rice S
(2), Chess J (4), Stephens JW (1,2).
(1) Department of Diabetes &
Endocrinology, Morriston Hospital, Swansea.
(2) Diabetes Research Group, School of Medicine, Swansea University,
Swansea.
(3) Data Science, Swansea University, Swansea.
(4) Renal Unit, Morriston Hospital, Swansea.
Click here to view poster
14
Effect of dapagliflozin on renal
function.
Min, T (1), Williams DM
(1), Wali L (1), Gurung A
(1), Plummer E (1), Price DE
(1), Stephens JW (1).
(1) Diabetes Unit, Morriston Hospital, Swansea.
Click here to view poster
15
Audit of secondary care diabetes and
renal follow up in patients with moderate to severe CKD.
Sabin, J (1), Dasgupta, T
(1),
Bhattacharya B (1).
(1) Great Western Hospital, Swindon.
Click here to view poster
16
A Comparison between the Joint Renal
Diabetes Clinic and General Diabetes Clinics in a District General
Hospital.
Idowu, O (1),
Jayashekara, A (1),
Chequer, S (1),
Hardy,D (1),
Summerhayes, B (1),
Zac-Varghese, S (1),
Winocour, P (1).
(1) ENHIDE, East and North Herts NHS Trust.
Click here to view poster
17
Anaemia in Patients with Diabetes and
Chronic kidney disease.
Jayashekara, A (1),
Idowu, O (1),
Chequer, S (1),
Hardy,D (1),
Summerhayes, B (1),
Zac-Varghese, S (1),
Winocour, P (1).
(1) ENHIDE, East and North Herts NHS Trust.
Click here to view poster
18
Assessing the prevalence of
cardiovascular risk factors amongst patients with diabetes and
chronic kidney disease.
Zac-Varghese, S (1),
Jayashekara, A (1),
Idowu, O (1),
Chequer, S (1),
Hardy,D (1),
Summerhayes, B (1),
Joharatnam, J (1),
Winocour, P (1).
(1) ENHIDE, East and North Herts NHS Trust.
Click here to view poster
19
Audit on the management of
microalbuminuria in people with Type 2 diabetes in secondary care.
Zaman, S (1), Mehta S (1),
Baynes K (1).
(1) Ealing Hospital, London North West Healthcare NHS Trust,
London.
Click here to view poster
|